In two systemic reviews of patients with anti-IFNγ auto-antibodies, 18.3%, respectively, 16.3% of these patients with anti-IFNγ auto-antibodies were diagnosed with talaromycosis [20,23], the second most common infection after NTM infections. The gene discussed is IFNG; the disease is infection.